Latest News - 康诺亚生物医药科技成都有限公司

CN

Latest News Media

News

More

Keymed Biosciences releases 2021 annual results

March 29, 2022, Chengdu, China - Keymed Biosciences Inc (HKEX: 02162) released 2021 annual results BUSINESS

2022-03-29
More

Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect

March 7, 2022, Chengdu, China -Keymed Biosciences Inc. (HKEX:02162) is pleased to announce that the shares of the C

2022-03-07
More

Keymed Bio joins Hang Seng Family of Indexes

February 18, 2022, Hong Kong – According to the quarterly review results of Hang Seng Family of Indexes, Keymed

2022-02-18
More

Keymed and InnoCare jointly announce dosing of first patient in clinical trial of CD20xCD3 bispecific antibody CM355

Chengdu, Jan. 18, 2022 –Keymed Biosciences (HKEX: 02162) and InnoCare Pharma (HKEX: 09969) jointly announced today...

2022-01-18

13条上一页 1 2 下一页